NEALS.ORG: Keyword Density Checker

Total words: 3294 | 2-word phrases: 843 | 3-word phrases: 967 | 4-word phrases: 1022

PAGE INFO

Title	Try to keep the title under 60 characters (58 characters) Northeast Amyotrophic Lateral Sclerosis Consortium \| NEALS
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	amyotrophic lateral sclerosis	5	0.52%
2	read more recruiting	5	0.52%
3	living with als	4	0.41%
4	our mission our	3	0.31%
5	center for als	3	0.31%
6	people living with	3	0.31%
7	2024400 pm500 pm	3	0.31%
8	participant enrolled in	3	0.31%
9	community education webinars	3	0.31%
10	healeyamg center for	3	0.31%
11	m healeyamg center	3	0.31%
12	screen grab jun	3	0.31%
13	a phase 12	3	0.31%
14	sean m healeyamg	3	0.31%
15	in people living	3	0.31%
16	the sean m	3	0.31%
17	study is to	3	0.31%
18	lateral sclerosis als	2	0.21%
19	dendrimer after intravenous	2	0.21%
20	for a trial	2	0.21%
21	search for a	2	0.21%
22	patients with amyotrophic	2	0.21%
23	to patients with	2	0.21%
24	administration to patients	2	0.21%
25	role of genetic	2	0.21%
26	agent 18fop801 18f	2	0.21%
27	hydroxyl dendrimer after	2	0.21%
28	an imaging agent	2	0.21%
29	with als does	2	0.21%
30	2024 annual neals	2	0.21%

#	Keyword	Frequency	Density
1	the sean m healeyamg	3	0.29%
2	sean m healeyamg center	3	0.29%
3	m healeyamg center for	3	0.29%
4	healeyamg center for als	3	0.29%
5	people living with als	3	0.29%
6	hydroxyl dendrimer after intravenous	2	0.20%
7	respiratory care in als	2	0.20%
8	of the als better	2	0.20%
9	the als better care	2	0.20%
10	als better care act	2	0.20%
11	care in als advances	2	0.20%
12	more recruiting a phase	2	0.20%
13	amyotrophic lateral sclerosis consortium	2	0.20%
14	northeast amyotrophic lateral sclerosis	2	0.20%
15	neals northeast amyotrophic lateral	2	0.20%
16	recruiting a phase 12	2	0.20%
17	lateral sclerosis als and	2	0.20%
18	study to evaluate the	2	0.20%
19	overview of the als	2	0.20%
20	first participant enrolled in	2	0.20%
21	an overview of the	2	0.20%
22	read more recruiting a	2	0.20%
23	patients with sod1 als	2	0.20%
24	in remote monitoring in	2	0.20%
25	remote monitoring in als	2	0.20%
26	have announced the first	2	0.20%
27	therapeutics have announced the	2	0.20%
28	rapa therapeutics have announced	2	0.20%
29	and rapa therapeutics have	2	0.20%
30	for als at massachusetts	2	0.20%
31	center for als at	2	0.20%
32	access for all in	2	0.20%
33	this study is to	2	0.20%
34	of this study is	2	0.20%
35	to evaluate the safety	2	0.20%
36	become a neals member	2	0.20%
37	the expanded access to	2	0.20%
38	macronutrients in people living	2	0.20%
39	genetic counseling for individuals	2	0.20%
40	specialist community education webinars	2	0.20%

#	URL	Whois	Check
1	https://investors.biogen.com/news-releases/news-release-details/fda-grants-accelerated-approval-qalsodytm-tofersen-sod1-als	Whois	biogen.com
2	https://investors.biogen.com/news-releases/news-release-details/fda-grants-accelerated-approval-qalsodytm-tofersen-sod1-als	Whois	biogen.com
3	https://www.massgeneral.org/neurology/als/news/first-participant-enrolled-rapa	Whois	massgeneral.org
4	https://www.massgeneral.org/neurology/als/news/first-participant-enrolled-rapa	Whois	massgeneral.org
5	https://www.nationalacademies.org/news/2024/06/report-urges-immediate-and-longer-term-actions-to-improve-quality-of-health-care-and-support-services-for-people-with-als-speed-development-of-therapies	Whois	nationalacademies.org
6	https://alsnewstoday.com/news/patient-guide-aims-increase-diversify-clinical-trial-participation/	Whois	alsnewstoday.com
7	https://www.massgeneral.org/neurology/als/news/first-participant-enrolled-prilenia	Whois	massgeneral.org
8	https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-formal-intention-to-remove-relyvrior/albriozatm-from-the-market-provides-updates-on-access-to-therapy-pipeline-corporate-restructuring-and-strategy	Whois	amylyx.com
9	https://neals.wildapricot.org/Sys/Login	Whois	wildapricot.org